Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -3.51M | -4.97M | -4.60M | -3.17M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 876.00K | 515.00K | 597.00K | 1.16M | 429.00K |
| Change in Net Operating Assets | -363.00K | -974.00K | 160.00K | -924.00K | 1.80M |
| Cash from Operations | -2.67M | -3.97M | -4.21M | -4.37M | -946.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 3.10M | -6.00K | 3.26M | 2.82M |
| Cash from Investing | 0.00 | 3.10M | -6.00K | 3.26M | 2.82M |
| Total Debt Issued | -- | -- | -- | -- | -13.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.05M | 495.00K | 3.00K | 8.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -571.00K | -82.00K | -- | -- | 0.00 |
| Cash from Financing | 2.48M | 413.00K | 3.00K | 8.00K | -13.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.00K | -459.00K | -4.22M | -1.10M | 1.86M |